Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALM.L Regulatory News (ALM)

  • There is currently no data for ALM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Formation of HawkEye 360

17 Sep 2015 07:00

RNS Number : 3120Z
Allied Minds PLC
17 September 2015
 



 

For immediate release

Allied Minds Announces the Formation of HawkEye 360

 

The company will use small satellites in low Earth orbit (LEO) to collect data, perform analytics and generate reports on wireless signals worldwide that can be used to monitor and track ships, planes and other transportation networks across air, land and sea, and assist with emergency response.

 

The three founders of HawkEye 360 bring valuable experience: Mr. Chris DeMay previously worked for the U.S. National Reconnaissance Office, leading programs for satellite development. Dr. Charles Clancy and Dr. Bob McGwier of Virginia Tech's Hume Center for National Security and Technology developed the associated technology for the complex RF signal processing.

 

 

Boston (September 17, 2015) - Allied Minds (LSE: ALM), an innovative U.S. science and technology development and commercialization company, announced the formation of HawkEye 360, Inc., which will use a constellation of small satellites in low Earth orbit (LEO) capable of detecting wireless signals that can be used to track and monitor global transportation networks, assist with emergencies, as well as other data analytics and reporting services to a broad range of customers.

 

HawkEye 360 seeks to provide highly accurate maritime situational awareness, collecting information about vessels to create a wealth of current and historical data useful for commercial planning as well as emergency response. Similar data will be available for planes, ground transportation, and logistics industries.

 

"HawkEye 360's technology will allow for unprecedented analysis of wireless signals," said John Serafini, Vice President at Allied Minds and Chief Executive Officer of HawkEye 360. "Space-based detection of RF signals allows us to accurately locate and characterize difficult-to-visualize spectrum information in a way that's both global and timely. You can't do that terrestrially, and you can't do that with photos."

 

Dr. Charles Clancy and Dr. Bob McGwier of Virginia Tech's Hume Center for National Security and Technology originally developed the data processing technology being licensed by Allied Minds. They are co-founding HawkEye 360 with Chris DeMay, who most previously worked for the National Reconnaissance Office. At the NRO, DeMay led programs for signals and satellite technology development for national security satellite collection systems, supporting the U.S. Department of Defense and the U.S. Intelligence Community. DeMay will be joining HawkEye 360 as Chief Operating Officer.

 

"We are developing a system that allows us to identify signals, locate signals, and visualize the information in a way that no one has before," said Chris DeMay, Chief Operating Officer of HawkEye 360. "The collaboration with Allied Minds provides an avenue for applying cutting-edge technologies to the commercial sector in a manner that creates previously unrealized value."

 

With the addition of this majority-owned subsidiary business, Allied Minds (LSE: ALM) now owns 23 subsidiaries.

 

 

About Allied Minds, Inc.Allied Minds is an innovative U.S. science and technology development and commercialization company. Operating since 2006, Allied Minds forms, funds, manages and builds products and businesses based on innovative technologies developed at leading U.S. universities and federal research institutions. Allied Minds serves as a diversified holding company that supports its businesses and product development with capital, central management and shared services. More information about the Boston-based company can be found at www.alliedminds.com.Allied Minds Forward-Looking StatementThis press release contains statements that are or may be forward-looking statements, including statements that relate to the company's future prospects, developments and strategies. The forward-looking statements are based on current expectations and are subject to known and unknown risks and uncertainties that could cause actual results, performance and achievements to differ materially from current expectations, including, but not limited to, those risk and uncertainties described in the risk factors included in the company's regulatory filings. These forward-looking statements are based on assumptions regarding the present and future business strategies of the company and the environment in which it will operate in the future. Each forward-looking statement speaks only as at the date of this press release. Except as required by law, regulatory requirement, the Prospectus Rules, the Listing Rules and the Disclosure and Transparency Rules, neither the company nor any other party intends to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise.

 

Media contact:

Christine Dunn

ArcPoint Strategic Communications

617.484.1660, x101

cdunn@arcpointstrategy.com

 

UK

Ben Atwell, Matthew Cole

FTI Consulting

+44 (0) 20 3727 1000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCDBGDCIDBBGUL
Date   Source Headline
31st Jan 20173:55 pmRNSTotal Voting Rights
30th Jan 201712:02 pmRNSPrice Monitoring Extension
3rd Jan 20172:48 pmRNSHolding(s) in Company
3rd Jan 20172:11 pmRNSTotal Voting Rights
13th Dec 20167:00 amRNSFormation of Signature Medical, Inc.
9th Dec 20165:04 pmRNSHolding(s) in Company
7th Dec 20164:34 pmRNSHolding(s) in Company
6th Dec 20165:05 pmRNSHolding(s) in Company
6th Dec 20165:04 pmRNSHolding(s) in Company
2nd Dec 20167:00 amRNSResults of equity placing
1st Dec 20164:50 pmRNSProposed Equity Placing
23rd Nov 20167:00 amRNSHawkEye 360 Raises $11m in Series A Financing
21st Nov 20167:00 amRNSFormation of Vatic Materials, Inc.
18th Nov 20163:15 pmRNSBlock Listing Six Monthly Return
11th Nov 20165:17 pmRNSHolding(s) in Company
24th Oct 20167:00 amRNSPrecision Biopsy Raises $5.0 Million
17th Oct 201612:07 pmRNSSecond Price Monitoring Extn
17th Oct 201612:02 pmRNSPrice Monitoring Extension
29th Sep 20167:00 amRNSAllied Minds & GE Ventures Form Strategic Alliance
8th Sep 201612:02 pmRNSPrice Monitoring Extension
31st Aug 20165:11 pmRNSTotal Voting Rights
25th Aug 20167:00 amRNSHalf-year Report
22nd Aug 20167:00 amRNSAllied Minds Secures $20m Debt Facility from SVB
22nd Aug 20167:00 amRNSAllied Minds' Subsidiary ABLS II Raises $15m
1st Aug 20167:00 amRNSSciFluor Enters Clinical Trial Stage
29th Jul 201610:30 amRNSTotal Voting Rights
13th Jul 201610:02 amRNSDirector/PDMR Shareholding
13th Jul 201610:01 amRNSDirector/PDMR Shareholding
13th Jul 201610:01 amRNSDirector/PDMR Shareholding
13th Jul 201610:00 amRNSDirector/PDMR Shareholding
7th Jul 20167:00 amRNSLong Term Incentive Plan - Listing Application
30th Jun 20167:00 amRNSTotal Voting Rights
22nd Jun 20164:41 pmRNSSecond Price Monitoring Extn
22nd Jun 20164:35 pmRNSPrice Monitoring Extension
14th Jun 20162:38 pmRNSDirector/PDMR Shareholding
13th Jun 20165:18 pmRNSDirector/PDMR Shareholding
31st May 20164:44 pmRNSBlocklisting Six Monthly Return
26th May 20165:23 pmRNSResult of AGM
26th May 20167:00 amRNSAGM Statement
25th May 20167:00 amRNSABLS II Completes Drug Feasibility Programme
13th May 20167:00 amRNSDirector/PDMR Shareholding
10th May 20164:30 pmRNSLong Term Incentive Plan
28th Apr 201612:33 pmRNSHolding(s) in Company
26th Apr 20167:00 amRNSAllied Minds Raises $80m for ABLS Capital
25th Apr 20167:00 amRNSAnnual Financial Report
19th Apr 20167:00 amRNSAppointment of Joint Broker
16th Mar 20167:00 amRNSABLS agrees license with NYU
10th Feb 20164:40 pmRNSSecond Price Monitoring Extn
10th Feb 20164:36 pmRNSPrice Monitoring Extension
9th Feb 20164:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.